| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 06/21/2012 | US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 06/21/2012 | US20120156186 Non-cytotoxic protein conjugates |
| 06/20/2012 | EP2465535A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 06/20/2012 | EP2465534A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 06/20/2012 | EP2465524A1 Autoantibody production inhibitor |
| 06/20/2012 | EP2464667A2 N-acylated octasaccharides activating fgfs receptors, their synthesis and their therapeutical application |
| 06/20/2012 | EP2464359A2 N-sulfated oligosaccharides activating fgfs receptors, their synthesis and their therapeutical application |
| 06/20/2012 | EP1601363B1 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 06/20/2012 | CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same |
| 06/20/2012 | CN102510754A Method for preparing polyphenol extracts from spinach leaves |
| 06/20/2012 | CN102503932A Novel gas signal molecule donator and preparation method and use thereof |
| 06/20/2012 | CN102499981A Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 06/20/2012 | CN102499952A Preparation method of Zanthoxylum acanthopodium lignan substances |
| 06/20/2012 | CN102499917A Application of indolone compounds in preparing nerve protection medicine |
| 06/19/2012 | CA2349202C Method of preparing stable suspensions of insoluble microparticles |
| 06/14/2012 | WO2012079057A2 Use of jasmonate for improving skeletal muscle function |
| 06/14/2012 | US20120149778 Compounds |
| 06/14/2012 | US20120149756 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease |
| 06/14/2012 | US20120149742 Heterocyclic derivatives as modulators of ion channels |
| 06/14/2012 | US20120149741 Treatment of duchenne muscular dystrophy |
| 06/14/2012 | US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors |
| 06/14/2012 | US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
| 06/14/2012 | US20120149673 Inhibitors of store operated calcium release |
| 06/14/2012 | US20120149655 Use of jasmonate to treat bladder dysfunction |
| 06/14/2012 | US20120148588 Methods for increasing thermogenic adipocytes |
| 06/14/2012 | US20120148587 Polypeptide formulation |
| 06/14/2012 | US20120148566 Product and method for treatment of conditions associated with receptor-desensitization |
| 06/14/2012 | US20120148540 Proliferated cell lines and uses thereof |
| 06/14/2012 | US20120148490 Anti-ngf compositions and use thereof |
| 06/13/2012 | EP1969125B1 Micrornas that regulate muscle cell proliferation and differentiation |
| 06/13/2012 | EP1296705B1 Amyloid Beta oligomers for use in treatment, alleviation or prevention of Alzheimer's Disease |
| 06/13/2012 | EP0451216B2 Humanized immunoglobulins and their production and use |
| 06/13/2012 | CN102498091A Glycine compound |
| 06/13/2012 | CN102492654A Kit for separating human umbilical cord blood stem cells and its using method |
| 06/13/2012 | CN102488760A Plaster for treating muscles and bones diseases and its preparation method |
| 06/13/2012 | CN102488713A Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution |
| 06/13/2012 | CN102488678A Application of embelin to preparation of medicament for treating autoimmune disease |
| 06/13/2012 | CN101810844B External plaster for preventing disease and manufacturing method thereof |
| 06/12/2012 | US8198483 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/12/2012 | US8198234 Methods of suppressing microglial activation |
| 06/07/2012 | WO2012075462A2 Methods and compositions for treatment of muscular dystrophy |
| 06/07/2012 | WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound |
| 06/07/2012 | US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 06/07/2012 | US20120142743 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate |
| 06/07/2012 | US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor |
| 06/07/2012 | US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs |
| 06/07/2012 | US20120141619 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 06/07/2012 | US20120141594 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy, and anti-cancer activity and methods of use |
| 06/07/2012 | US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 06/07/2012 | US20120141451 Fibroblast growth factor receptor-derived peptides binding to ncam |
| 06/07/2012 | US20120141449 Albumin Fusion Proteins |
| 06/07/2012 | US20120141448 Method for increasing muscle mass and strength |
| 06/07/2012 | US20120141445 Nutrition for improving muscle strength in elderly |
| 06/07/2012 | US20120141441 Methods and Compositions for Treatment of Muscular Dystrophy |
| 06/07/2012 | US20120141428 Muscle-derived cells (mdcs) for treating muscle- or bone-related injury or dysfunction |
| 06/07/2012 | US20120141415 Albumin Fusion Proteins |
| 06/07/2012 | US20120141383 Preparation comprising a creatine component, method for the production thereof, and the use thereof |
| 06/06/2012 | EP2460806A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 06/06/2012 | EP2460537A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 06/06/2012 | EP2459198A1 Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia |
| 06/06/2012 | CN101663301B Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 06/05/2012 | US8193195 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 06/05/2012 | US8192987 Human dental follicle stem cells and methods for obtaining |
| 06/05/2012 | US8192732 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 06/05/2012 | CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 05/31/2012 | WO2012068981A1 6-deoxy-6-thioether-amino acid cyclodextrin derivatives and preparation method thereof |
| 05/31/2012 | US20120137379 Novel aav's and uses thereof |
| 05/31/2012 | US20120136046 Method of treating age related disorders |
| 05/31/2012 | US20120135964 Certain chemical entities, compositions, and methods |
| 05/31/2012 | US20120135932 Compositions And Methods For Treating Ischemia And Ischemia-Reperfusion Injury |
| 05/31/2012 | US20120135921 Tripetide boronic acid or boronic ester, preparative method and use thereof |
| 05/31/2012 | US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction |
| 05/31/2012 | US20120135008 Methods and compositions for targeting polyubiquitin |
| 05/31/2012 | US20120134976 Oral formulations for counteracting effects of aging |
| 05/31/2012 | US20120134966 Embryonic stem cell specific micrornas promote induced pluripotency |
| 05/30/2012 | EP2457923A1 Sterol derivative |
| 05/30/2012 | EP2457585A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 05/30/2012 | EP2457567A1 Agent having neurotrophic factor-like activity |
| 05/30/2012 | EP2456448A1 Methods of attenuating the loss of functional status |
| 05/30/2012 | EP2303297B1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism |
| 05/30/2012 | CN1642558B Uses of sapogenins and their derivatives |
| 05/30/2012 | CN102481340A 干细胞靶向 Stem cell targeting |
| 05/30/2012 | CN102481289A 治疗与蛋白激酶ck2活性有关的疾病的方法 Method of treating a protein kinase related to the activity of the disease ck2 |
| 05/30/2012 | CN102475692A Transdermal patch preventing rasagiline from volatilizing |
| 05/30/2012 | CN102008551B Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof |
| 05/30/2012 | CN101646678B Heteroaryl derivative |
| 05/30/2012 | CN101590189B Traditional Chinese medicine composition containing radix aconiti carmichaeli for treating myasthenia gravis and preparation thereof |
| 05/30/2012 | CN101563320B [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 05/30/2012 | CN101254185B Use of cyclic enol ether terpenoid for producing promotive neurocyte proliferate and differentiation medicament |
| 05/29/2012 | US8188216 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 05/29/2012 | US8188146 Highly purified ethyl EPA and other EPA derivatives |
| 05/29/2012 | US8188066 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 05/29/2012 | CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same |
| 05/29/2012 | CA2440767C Novel neurotrophic factors |